Changes

The '''Pfizer COVID vaccine''' was first approved in the [[United Kingdom]] late in 2020, for those over 16 years old.

The '''Pfizer COVID vaccine''' was first approved in the [[United Kingdom]] late in 2020, for those over 16 years old.

It is a novel mRNA vaccine, having data on merely 30,000 patients.  The follow-up monitoring consisted of only two months. It creates abnormal proteins that attack the female reproductive system.

It is a novel mRNA vaccine, having data on merely 30,000 patients.  The follow-up monitoring consisted of only two months.  

 

On Dec. 9, 2020, [[Pfizer]] issued a warning for those having allergies:

On Dec. 9, 2020, [[Pfizer]] issued a warning for those having allergies:

{{cquote|Two people who were jabbed with Pfizer’s recently-approved coronavirus vaccine in the UK had to be treated for serious adverse reactions — leading to warnings that those with “significant” allergies may not be able to get it.<ref>https://nypost.com/2020/12/09/uk-issues-warning-about-pfizers-covid-19-vaccine/</ref>}}

{{cquote|Two people who were jabbed with Pfizer’s recently-approved coronavirus vaccine in the UK had to be treated for serious adverse reactions — leading to warnings that those with “significant” allergies may not be able to get it.<ref>https://nypost.com/2020/12/09/uk-issues-warning-about-pfizers-covid-19-vaccine/</ref>}}